Fortrea Holdings (FTRE) Common Equity (2022 - 2026)
Fortrea Holdings (FTRE) reported Common Equity of $525.9 million for Q1 2026, down 38.76% on a YoY basis from $858.8 million in Q1 2025, and down 6.67% quarter-over-quarter from $563.5 million in Q4 2025.
Fortrea Holdings (FTRE) Common Equity (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Common Equity for 5 years, with the latest figure at $525.9 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity fell 38.76% year-over-year to $525.9 million; the trailing twelve-month figure through Mar 2026 stood at $525.9 million (down 38.76% YoY), and the FY2025 full-year result was $563.5 million, down 58.64% from the prior year.
- Common Equity for Q1 2026 stood at $525.9 million, down from $563.5 million in the prior quarter.
- The five-year high for Common Equity was $3.4 billion in Q1 2023, with the low at $525.9 million in Q1 2026.
- Historically, Common Equity has averaged $1.6 billion across 5 years, with a median of $1.5 billion in 2024.
- Annual changes were most pronounced in 2024 — Common Equity declined 10.47% — and 2025, when it sank 61.63%.
- Fortrea Holdings' Common Equity stood at $3.3 billion in 2022, then sank by 48.68% to $1.7 billion in 2023, then decreased by 20.52% to $1.4 billion in 2024, then sank by 58.64% to $563.5 million in 2025, then slipped by 6.67% to $525.9 million in 2026.
- The last three Common Equity figures came in at $525.9 million (Q1 2026), $563.5 million (Q4 2025), and $580.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 525.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 525.90 Mn |
| Dec 31, 2025 | 563.50 Mn |
| Sep 30, 2025 | 580.80 Mn |
| Jun 30, 2025 | 589.20 Mn |
| Mar 31, 2025 | 858.80 Mn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.51 Bn |
| Jun 30, 2024 | 1.46 Bn |
| Mar 31, 2024 | 1.59 Bn |
| Dec 31, 2023 | 1.71 Bn |
| Sep 30, 2023 | 1.69 Bn |
| Jun 30, 2023 | 1.75 Bn |
| Mar 31, 2023 | 3.40 Bn |
| Dec 31, 2022 | 3.34 Bn |
| Jun 30, 2022 | 3.30 Bn |